Start up companies and biotech engineering is making a big calling as nobody wants or likes the formulas that crippled Wall Street any longer. There’s a lot of work in R and D though where formulas and scientific study are needed to cure diseases, that is for sure. Hopefully all our well educated...
Posted to
The Medical Quack .... by Barbara Duck
on 11-14-2008
Filed under: Medically Related, Technology, Other Items of Interest, Genomics, healthcare, Biotech, Start Ups, Wall Street, Algorithms, Engineers
The tweezers grab a piece of target DNA and release it on-demand using a controlled series of hydrogen bonding and pH changes. The process of getting the tweezers to grasp and release. This is the first one that can grasp and release, as there have been other developments in this area...
The bar has also risen on Venture Capital money and is harder to get, and so much of the research is still in the “Science” stage, there have been a few companies that have had failed products and just folded up and went away. This certainly leaves the door open for Pharma, who has the financials...
Posted to
The Medical Quack .... by Barbara Duck
on 10-29-2008
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, Pharma, Biotech, Science, R and D, Venture Capitalists
This interview from Charlie Roses touches on many items and Nobel Prize Winner Muhammad Yunus adds what he has been able to accomplish in his part of the world in Bangladesh and how some of those principles can be applied here, coming together of both sides, different minds, different ideas that can...
Posted to
The Medical Quack .... by Barbara Duck
on 10-28-2008
Filed under: Medically Related, Insurance, Other Items of Interest, My Commentaries, healthcare, Biotech, Cancer, Pharmaceuticals, R and D, Economy, Banking, Milken Institute, Mahammed Yunus, Milken, Charlie Rose
A biotech company caught in the wrong place at the wrong time. They do have some substantial customers using products so it might take time to see how things fall in to place. Certain elements of biotech have not been untouched by the economy as well. BD Over the last few weeks...
Posted to
The Medical Quack .... by Barbara Duck
on 10-17-2008
Filed under: Medically Related, Other Items of Interest, Biotech, Stanford University, DNA Testing, Scripps, Venture Capitalists, valuation, sequency, equity, IPO. Sequencing
The economy is also affecting some of the work and business design of genetic companies. DeCode is is Iceland with offices here in Illinois as well. Biotech companies are starting to feel the crunch as well, even those with breakthrough technology in personalized medicine and part of what...
Posted to
The Medical Quack .... by Barbara Duck
on 10-16-2008
Filed under: Medically Related, Other Items of Interest, personalized medicine, Genomics, Biotech, DeCode, DNA Testing, pharamcogenomics
It has been a big day at Stanford with genomics, not only was the announcement made to better use sequencing to predict own syndrome, but they are also just about ready to receive their new genomic sequencing machine from Helicos. Earlier this year I interviewed Dr. Patrice Milos, Chief Science...
Posted to
The Medical Quack .... by Barbara Duck
on 10-07-2008
Filed under: Medically Related, Technology, Other Items of Interest, My Commentaries, personalized medicine, Genomics, healthcare, Electronic Medical Records, Biotech, cancer research, Research, Gene Sequencing, Disease, Stanford University, DNA Testing, Phamaceuticals, Helicos, Donation